Patent Assignment
Reel/Frame 072159/0497
Release of Security Interest
Recorded: 2025-09-04
Pages: 8
Assignors
NEW MEXICO MEZZANINE PARTERSN, L.P.
Executed: 2025-06-13
NEW MEXICO CO-INVESTMENT FUND, L.P.
Executed: 2025-06-13
Assignee
EXAGEN INC.
1261 LIBERTY WAY, SUITE C, VISTA, CALIFORNIA, 92081
Covered Properties
(19)
Biomarkers for Inflammatory Bowel Disease and Irritable Bowel Syndrome
PCT:
PCT/US2009/037065 ↗
Methods and Devices Relating to Estimating Classifier Performance
Methods for in situ hybridization without the need for competitior DNA
Application:
10/833,954 →
Publication:
US 2004/0241734
Compositions for Glioma Classification
Compositions and methods for breast cancer prognosis
Application:
11/112,908 →
Publication:
US 2005/0260659
Unique sequence hybridization probes (USP)
Application:
11/112,926 →
Publication:
US 2006/0223075
Breast cancer gene expression biomarkers
Application:
11/112,944 →
Publication:
US 2005/0244872
Methods for RNA fluorescence in situ hybridization
Application:
11/159,799 →
Publication:
US 2005/0287578
Acute Myelogenous Leukemia Biomarkers
Compositions and methods for glioma classification
Application:
12/387,555 →
Publication:
US 2009/0253139
Biomarkers for Inflammatory Bowel Disease and Irritable Bowel Syndrome
Biomarkers for Inflammatory Bowel Disease and Irritable Bowel Syndrome
Biomarkers for Inflammatory Bowel Disease and Irritable Bowel Syndrome
Acute Myelogenous Leukemia Biomarkers
Application:
12/478,930 →
Publication:
US 2009/0258370
Methods and Devices Relating to Estimating Classifier Performance
Biomarkers for Inflammatory Bowel Disease and Irritable Bowel Syndrome
Biomarkers for Inflammatory Bowel Disease and Irritable Bowel Syndrome
Biomarkers for Inflammatory Bowel Disease and Irritable Bowel Syndrome
Biomarkers for Ulcerative Colitis and Crohn's Disease
Application:
61/322,397 →
Related Assignments
(5)
Other recorded transfers of the patents in this record — the chain of ownership.
Short-Form Patent Security Agreement
Oct 15, 2013
From: EXAGEN DIAGNOSTICS, INC.
To: CAPITAL ROYALTY PARTNERS II L.P.; CAPITAL ROYALTY PARTNERS II - PARALLEL FUND "A" L.P.; PARALLEL INVESTMENT OPPORTUNITIES PARTNERS II L.P.
Reel/Frame 031414/0660 →
Release of Security Interest
Sep 7, 2017
From: CAPITAL ROYALTY PARTNERS II L.P.; CAPITAL ROYALTY PARTNERS II - PARALLEL FUND "A" L.P.; PARALLEL INVESTMENT OPPORTUNITIES PARTNERS II L.P.
To: EXAGEN DIAGNOSTICS, INC.
Reel/Frame 043784/0828 →
Security Interest
Sep 11, 2017
From: EXAGEN DIAGNOSTICS, INC.
To: INNOVATUS LIFE SCIENCES LENDING FUND I, LP, AS COLLATERAL AGENT
Reel/Frame 043548/0228 →
Release of Security Interest
Apr 25, 2025
From: INNOVATUS LIFE SCIENCES LENDING FUND I, LP
To: EXAGEN INC.
Reel/Frame 070951/0040 →
Security Interest
Apr 25, 2025
From: EXAGEN INC.
To: PERCEPTIVE CREDIT HOLDINGS IV, LP
Reel/Frame 070952/0802 →